€232.10
1.66% today
Xetra, Mar 12, 11:45 am CET
ISIN
DE0007165631
Symbol
SRT3
Index
Sector

Sartorius Vz Stock price

€228.30
-20.80 8.35% 1M
-20.90 8.39% 6M
+13.10 6.09% YTD
-130.30 36.34% 1Y
-131.70 36.58% 3Y
+29.30 14.72% 5Y
+197.41 639.13% 10Y
Xetra, Closing price Tue, Mar 11 2025
+2.60 1.15%
ISIN
DE0007165631
Symbol
SRT3
Index
Sector

Key metrics

Market capitalization €15.76b
Enterprise Value €20.64b
P/E (TTM) P/E ratio 187.56
EV/FCF (TTM) EV/FCF 57.98
EV/Sales (TTM) EV/Sales 6.11
P/S ratio (TTM) P/S ratio 4.66
P/B ratio (TTM) P/B ratio 5.70
Dividend yield 0.32%
Last dividend (FY24) €0.74
Revenue growth (TTM) Revenue growth -0.44%
Revenue (TTM) Revenue €3.38b
EBIT (operating result TTM) EBIT €580.10m
Free Cash Flow (TTM) Free Cash Flow €356.00m
Cash position €813.40m
EPS (TTM) EPS €1.22
P/E forward 65.00
P/S forward 4.33
EV/Sales forward 5.67
Show more

Create a Free Account to create an Sartorius Vz alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Sartorius Vz Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Sartorius Vz forecast:

12x Buy
55%
8x Hold
36%
2x Sell
9%

Analyst Opinions

22 Analysts have issued a Sartorius Vz forecast:

Buy
55%
Hold
36%
Sell
9%

Financial data from Sartorius Vz

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
3,381 3,381
0% 0%
100%
- Direct Costs 1,857 1,857
2% 2%
55%
1,524 1,524
3% 3%
45%
- Selling and Administrative Expenses 331 331
15% 15%
10%
- Research and Development Expense 197 197
15% 15%
6%
996 996
1% 1%
29%
- Depreciation and Amortization 416 416
22% 22%
12%
EBIT (Operating Income) EBIT 580 580
13% 13%
17%
Net Profit 84 84
59% 59%
2%

In millions EUR.

Don't miss a Thing! We will send you all news about Sartorius Vz directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sartorius Vz Stock News

AD HOC NEWS
15 days ago
Die britische Investmentbank Barclays hat Sartorius DE0007165631 von "Equal Weight" auf "Overweight" hochgestuft und das Kursziel von 260 auf 320 Euro angehoben.
AD HOC NEWS
24 days ago
Sartorius haben am Montag angesichts von Spekulationen über mögliche Anteilsverkäufe durch einen Großaktionär im starken Gesamtmarkt nachgegeben.Die Sartorius-Vorzüge DE0007165631 verloren am Nachmittag im Dax DE0008469008 1,0 Prozent auf 244,40 Euro.
AD HOC NEWS
24 days ago
SARTORIUS AG / DE0007165631
More Sartorius Vz News

Company Profile

Sartorius AG is an international laboratory and process technology provider for the biotech, pharmaceutical, and food industries. It operates through the Bioprocess Solutions and Lab Products and Services divisions. The Bioprocess Solutions division focuses on the major areas of activity of filtration, fluid management, fermentation, and purification. The Lab Products and Services division focuses on lab balances, pipettes, and laboratory water purification systems. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.

Head office Germany
CEO Joachim Kreuzburg
Employees 13,528
Founded 1870
Website www.sartorius.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today